Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 14, 2011

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Incivek New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Victrelis New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Natroba New Drug Initial Review Require Prior Approval Prior Approval Required
Xarelto New Drug Initial Review Remove Prior Approval Requirement Preferred and Require Prior Approval
Tradjenta New Drug Initial Review Require Prior Approval Prior Approval Required
Moxeza New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required